Cargando…
Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
It is well acknowledged that allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for numerous malignant blood diseases, which has also been applied to autoimmune diseases for more than a decade. Whereas graft-versus-host disease (GVHD) occurs after allogeneic hem...
Autores principales: | Zhou, Xinyi, Jin, Nan, Wang, Fei, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137413/ https://www.ncbi.nlm.nih.gov/pubmed/32280306 http://dx.doi.org/10.1186/s12935-020-01193-z |
Ejemplares similares
-
Mesenchymal Stem Cell Therapy in the Treatment of Acute and Chronic Graft Versus Host Disease
por: Kebriaei, Partow, et al.
Publicado: (2011) -
Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
por: Amorin, Bruna, et al.
Publicado: (2014) -
Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease
por: Kim, YongHwan, et al.
Publicado: (2018) -
Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019) -
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)